Evaluation of cell cycle arrest in estrogen responsive MCF-7 breast cancer cells: pitfalls of the MTS assay.
Endocrine resistance is a major problem with anti-estrogen treatments and how to overcome resistance is a major concern in the clinic. Reliable measurement of cell viability, proliferation, growth inhibition and death is important in screening for drug treatment efficacy in vitro. This report descri...
Main Authors: | Eileen M McGowan, Nikki Alling, Elise A Jackson, Daniel Yagoub, Nikolas K Haass, John D Allen, Rosetta Martinello-Wilks |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2011-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3108819?pdf=render |
Similar Items
-
A Chip for Estrogen Receptor Action: Detection of Biomarkers Released by MCF-7 Cells through Estrogenic and Anti-Estrogenic Effects
by: Konstanze Gier, et al.
Published: (2017-08-01) -
Apoptosis in Response to Anti-estrogens in MCF-7 Human Mammary Adenocarcinoma Cells
by: Avrum Jacobson, et al.
Published: (2020-12-01) -
Regorafenib Suppresses Migration of and Induces Cell Cycle Arrest and Apoptosis in MCF-7 Cells
by: Dawei Wang, et al.
Published: (2021-10-01) -
Characterization of MCF-12A cell phenotype, response to estrogens, and growth in 3D
by: Michael F. Sweeney, et al.
Published: (2018-03-01) -
Two estrogen response element sequences near the PCNA gene are not responsible for its estrogen-enhanced expression in MCF7 cells.
by: Cheng Wang, et al.
Published: (2008-01-01)